Overview

Pertussis Challenge Study in Adults Vaccinated With BPZE1

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a randomised, double-blinded, placebo-controlled trial of BPZE1 that includes virulent B. pertussis challenge followed by a safety follow-up.
Phase:
Phase 2
Details
Lead Sponsor:
ILiAD Biotechnologies
Treatments:
Azithromycin